Levesam 500 Tablet contains Levetiracetam 500 mg, an antiepileptic medication indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and pediatric patients. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby stabilizing neuronal activity and preventing seizure propagation. This medication is typically used as adjunctive therapy in patients with epilepsy who have not achieved adequate seizure control with other antiepileptic drugs. Levesam 500 Tablet is administered orally, with dosage individualized based on patient age, renal function, and clinical response. Common adverse effects may include somnolence, dizziness, headache, and fatigue, while serious side effects such as behavioral changes, mood disturbances, or hypersensitivity reactions require prompt medical attention. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Levesam 500 Tablet should be used under strict medical supervision, with regular monitoring for efficacy and tolerability. Patients are advised not to discontinue therapy abruptly to avoid increased seizure risk. This medication is contraindicated in individuals with known hypersensitivity to Levetiracetam or any of its excipients.